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Abstract
Background: A colonoscopy may frequently miss polyps and cancers. A number of techniques have emerged to
improve visualization and to reduce the rate of adenoma miss.
Methods: We conducted a randomized controlled trial (RCT) in two clinics of the Gastrointestinal Department of
the Sanitas University Foundation in Bogota, Colombia. Eligible adult patients presenting for screening or
diagnostic elective colonoscopy were randomlsy allocated to undergo conventional colonoscopy or narrow-band
imaging (NBI) during instrument withdrawal by three experienced endoscopists. For the systematic review, studies
were identified from the Cochrane Library, PUBMED and LILACS and assessed using the Cochrane risk of bias tool.
Results: We enrolled a total of 482 patients (62.5% female), with a mean age of 58.33 years (SD 12.91); 241 into
the intervention (NBI) colonoscopy and 241 into the conventional colonoscopy group. Most patients presented for
diagnostic colonoscopy (75.3%). The overall rate of polyp detection was significantly higher in the conventional
group compared to the NBI group (RR 0.75, 95%CI 0.60 to 0.96). However, no significant differences were found in
the mean number of polyps (MD -0.1; 95%CI -0.25 to 0.05), and the mean number of adenomas (MD 0.04 95%CI
-0.09 to 0.17). Meta-analysis of studies (regardless of indication) did not find any significant differences in the mean
number of polyps (5 RCT, 2479 participants; WMD -0.07 95% CI -0.21 to 0.07; I2 68%), the mean number of
adenomas (8 RCT, 3517 participants; WMD -0.08 95% CI -0.17; 0.01 to I2 62%) and the rate of patients with at least
one adenoma (8 RCT, 3512 participants, RR 0.96 95% CI 0.88 to 1,04;I2 0%).
Conclusion: NBI does not improve detection of colorectal polyps when compared to conventional colonoscopy
(Australian New Zealand Clinical Trials Registry ACTRN12610000456055).
Keywords: Randomized controlled trial, colonoscopy, polyps, narrow-band imaging
Background
Screening for colorectal cancer using fecal occult blood
testing, sigmoidoscopy, or colonoscopy is recommended
in several countries in people above 50 years of age with
an average risk and earlier in people with a strong
family history or other risk factors [1-3]. Adenomatous
polyps are deemed to be precursors of colorectal cancer.
Some studies have shown that removal of polyps and
postpolypectomy surveillance decreases the incidence of
colorectal cancer [1,4-6].
Colonoscopy is considered to be the reference stan-
dard against which the sensitivity of other colorectal
cancer screening tests is compared [1-3]. However,
assessing the sensitivity and specificity of colonoscopy
by comparing colonoscopy versus tandem colonoscopies,
CT colonography and colonic specimens showed that
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[7-9]. Meta-analysis of six studies [7] found that the
miss rate for polyps of any size was 22% (95% CI: 19 to
26%). The study also reported that the adenoma miss
rate was 2.1%, 13%, and 26% for polyp sizes of 10 mm
and higher, 5-10 mm and 1-5 mm respectively. In
another study, the diameter and the number of polyps
(≥ 3) were independently associated with a lower polyp
miss rate, whereas sessile or flat shape was significantly
associated with a higher miss rate [8]. Simmons et al.
analyzed 10,955 colonoscopies performed by 43 endos-
copists and found that longer withdrawal time was also
associated with higher polyp detection rate, particularly
for smaller polyps [10]. Another study found that most
advanced adenomas (74%) and cancers (95%) were
detected during the insertion [11].
Diverse reasons for the miss rate have been suggested,
including incomplete colonoscopy, the quality of bowel
preparation, lesion characteristics (location, number,
shape and size), the endoscopist’s experience, the opera-
tor’s insertion and the withdrawal technique [8-12].
A number of techniques have emerged to improve
visualization and to reduce the adenoma miss rate [13].
The narrow-band imaging (NBI) technology in conven-
tional video colonoscopes uses special filters to narrow a
light source, eliminating red, enhancing structures and
rendering vascular structures in black [14-18]. During
the conduction of this research, a number of other stu-
dies comparing the NBI technique with conventional
colonoscopy have been published [19-34].
The objective of this randomized controlled trial
(RCT) was to evaluate the effectiveness of NBI during
colonoscopy withdrawal compared to the conventional
procedure in detecting polyps and adenomas. The objec-
tive of the systematic review was to identify and evaluate
all RCT that assessed the effectiveness of diagnostic and
screening conventional colonoscopy compared to NBI
colonoscopy in detecting polyps and adenomas.
Methods
This open-label randomized controlled trial (RCT) was
conducted at the Gastrointestinal Department of two
private clinics (Clinica Reina Sofia and Clinica Colom-
bia), both tertiary care referral centers, during a nine-
month study period. All consecutive adult patients pre-
senting for screening or diagnostic colonoscopy for a
variety of indications (e.g. positive fecal occult blood
test, abdominal pain, post-polypectomy surveillance,
diarrhea) were eligible for the RCT. Patients were
excluded if they had known colonic neoplasia, inflam-
matory or another significant colonic disease (e.g. fulmi-
nant colitis, documented acute diverticulitis); if they had
previously undergone colorectal surgery; if they had had
a previous colonoscopy in the last 12 months before
enrollment; if there was known familial adenomatous
polyposis; if they were specifically presenting for poly-
pectomy or emergency colonoscopy; if they were receiv-
ing anticoagulant medication; when adequate patient
cooperation or consent could not be obtained; if the
patient had a contraindication for the procedure; and in
the cases of poor bowel preparation; active bleeding; or
pregnancy. The trial protocol was approved by the Insti-
tutional Review Board of the Research Institute of the
Medical School of the Sanitas University Foundation;
written and informed consent was obtained from all the
patients enrolled in the study. The study was registered
in the Australian New Zealand Clinical Trials Registry
ACTRN12610000456055.
Assignment to interventions
During the first part of the procedure, the colonoscope
was inserted through the rectum and advanced to the
large intestine using conventional colonoscopy in both
groups (we did not use chromoendoscopy during the
process of conventional colonoscopy observation).
Thereafter, patients were randomly assigned to colono-
scope withdrawal using either conventional wide-angle
or NBI wide-angle colonoscopy (Olympus Corp: Olym-
pus 180, CF-Q180AL#2) in examinations conducted by
a total of three experienced examiners (each with over
5,000 colonoscopies performed and more than 15 years
of experience, including a minimum of two years of
experience with NBI colonoscopy). The colonoscopies
were performed using high definition monitors. Appro-
priate and complete bowel preparation before colono-
scopy was ensured using four liters of polyethylene
glycol lavage until clear rectal fluid was evacuated and a
cleaning enema. We categorized the quality of bowel
preparation into excellent, good, fair, poor or
inadequate.
Randomization was performed in blocks of 4 and 6
using a random table. Once the caecum had been
reached and appropriate bowel preparation confirmed,
an opaque sealed envelope with sequential numbering
was opened and participants were allocated to either
NBI or conventional colonoscopy withdrawal of the
instrument.
Polypectomies were performed in the same session
during withdrawal when possible. Polyps were removed
using snare polypectomy or forceps biopsy, depending
on the size of the polyps.
Outcome measures
Baseline Characteristics
The following demographic data and medical history
information were obtained before randomization for
every eligible patient: gender, age, weight, height, indica-
tion for colonoscopy, previous colonoscopy, date of last
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tory of colorectal cancer.
Primary outcome measure
1. Mean number of detected polyps and adenomas
2. Total number of polyps
Secondary outcome measure
1. Polyp detection rate (at least one polyp per patient)
2. Polyp size
3. Location
4. Total number of adenomas smaller than 5 mm
5. Time before finding the first polyp.
6. Final histological result. Histological studies were
performed on all removed polyps.
7. Adverse events
Sample size determination
The primary endpoint for this study was the mean num-
ber of detected polyps. We assumed from institutional
data that the mean number of polyps per patient in the
control group would be 0.32, with a standard deviation
(SD) of 0.31. A clinically significant increase in polyp
detection using the NBI system was determined to be
25%. Using a two-tail alpha error of 0.05, and beta error
of 0.20 (power > 80%), 240 patients in each arm would
be required to detect a difference.
Data management and analysis
The database, created in Excel, was double-checked and
transferred to SPSS 15.0
©. Categorical variables were
compared using the chi-square test. To evaluate the
continuous variables, Student’s t-test was used; P < 0.05
was considered statistically significant. The measure-
ment of the intervention effect for dichotomous out-
comes was the risk ratio (RR). The measurement of the
intervention effect for continuous outcomes was
assessed by the mean difference (MD).
Systematic review of the current evidence
During the conduction of this study, a number of other
RCTs comparing the NBI technique with conventional
colonoscopy were published. We performed an
advanced search strategy of studies comparing the con-
ventional colonoscopy to NBI to detect colorectal
polyps/adenomas (appendix 1). Relevant RCTs were
identified from the Cochrane Library (2009, Issue 4),
PUBMED (1966-December 2009), LILACS (1982-
December 2009) and Scirus (http://www.scirus.com;
December 2009). We also scanned bibliographies of
relevant studies for possible references to additional
RCT. Two authors independently decided which trials
fit the inclusion criteria. Eligible RCT were included
regardless of the language of publication. Two reviewers
independently extracted the relevant data using a pre-
designed data extraction form and any disagreement
was resolved by consensus with all authors. We
extracted year of publication; patient population; num-
ber of patients (by intention to treat); sociodemo-
graphics; endoscopic, and histologic outcomes; and
adverse effects. The main outcomes considered were the
mean number of polyps, the mean number of adenomas
and the rate of patients with at least one adenoma.
A risk of bias evaluation of each RCT was done fol-
lowing the Cochrane Collaboration’s tool for the assess-
ment of these features [35]. To estimate differences
between treatments we calculated a weighted treatment
effect across RCTs. We expressed the results as risk
ratio (RR) with 95% confidence intervals (CI) for dichot-
omous outcomes and weighted mean difference (WMD)
with 95% CI for continuous outcomes. We imputed
conservative standard deviations where necessary using
the p-value from an independent two-sample t-test [35].
For the pooled analysis, we calculated the I2 statistic,
which describes the percentage of total variation across
studies caused by heterogeneity [35].
Results
Randomized Controlled Trial
Patients were enrolled during a three month period at
the Reina Sofia Clinic and during a 2 month period at
the Clinica Colombia, between September 2008 and
May 2009. We included a total of 482 patients (62.5%
female), with a mean age of 58.33 years (SD 12.91); 241
into the intervention (NBI) colonoscopy and 241 into
the conventional colonoscopy group. Patients were
enrolled during a three month period at the Reina Sofia
Clinic and during a 2 month period at the Clinica
Colombia.
The flow of participants through each stage of the
randomized trial is described in Figure 1. Most polyps
(67%) were found in the left colon; no significant dif-
ference was found between groups with regards to the
location of the polyps. The total examination time did
not differ significantly between the two groups (9.21
vs. 9.22; excluding polypectomy duration). Baseline
characteristics of patients were similar among groups
(Table 1).
The overall polyp detection rate per patient by visual
inspection in the entire study group was 37.14% (77
polyps in the NBI group versus 102 in the conventional
group). There was no protocol deviation, however 2.8%
of visualized polyps were not available for histological
analysis because polypectomy was delayed and no
further procedure was performed until the termination
of the study (Table 2).
No significant difference was found in the mean num-
ber of polyps when comparing the conventional proce-
dure to the NBI system (0.41 vs. 0.29). The overall
detection rate of lesions (n = 174) and polyps (n = 169)
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study group were 36.1% and 35.1% respectively, with
adenomas and hyperplastic polyps found, respectively, in
55.0% (n = 93/169) and 37.9% (n = 64/169) of all
patients; tubulovillous and villous adenomas were found
in 7,1% of polyps (Table 3). The overall rate of polyp
detection was significantly higher in the conventional
group compared to the NBI group (RR 0.75, 95% CI
0.60 to 0.96). Significant differences were also found in
the rate of hyperplastic (RR 0.52, 95% CI 0.32 to 0.85; p
= 0.009) and tubulovillous polyps (RR 0.11, 95% 0.01 to
0.87; p = 0.009). However, no significant differences
were found in the mean number of polyps, the rate of
polyps measuring less than 5 mm or the mean time to
find the first polyp (Table 2).
Of the adenomas, 9% were high-grade, with no signifi-
cant difference between groups. Two adenocarcinomas
were found (one in each group). There were no differ-
ences between the different examiners in the rate of
detection of adenomatous and hyperplastic polyps. No
serious adverse events were reported among groups dur-
ing the procedure.
Systematic Review of the current evidence
A total of 167 citations were identified from the
diverse sources of information (Figure 2). Of the six-
teen potentially RCTs screened [19-34], we excluded
nine references because they were nonrandomized,
they focused on predicting colon polyp histology, or
they used other devices. Finally, seven RCTs meet the
inclusion criteria [19-21,23,25-27] one of which was
published as an abstract [27]. Characteristics of RCTs
included in the meta-analysis are described in Table 4.
One study was judged as having low risk of bias [21]
and six RCTs were judged as having unclear risk of
bias because the description of the method used to
generate to conceal the allocation was unclear
[19,20,23,27]; only one evaluator performed all the
colonoscopies [25]; inadequate distribution of the NBI
Figure 1 Flow of participants through each stage of the
randomized trial.
Table 1 Baseline characteristics of patients and colonoscopy performance
Parameter NBI group (n = 241) Conventional group (n = 241) Significance (p)
Age (years) 57.36 (SD 12.07) 59.29 (SD 12.91) Ns
Gender M/F 86/155 95/146 Ns
Weight (kg) 66.73 (SD 12.99) 66.43 (SD 12.45) Ns
Height (cm) 163.49 (SD 11.37) 163.11 (SD 8.57) Ns
Total examination time (min)* 9.21 (SD 3.08) 9.22 (SD 3.58) Ns
Previous colonoscopy 94 (39.0%) 98 (40.7%) Ns
Indication:
Screening 42 (17.4%) 37 (15.4%) Ns
Surveillance 22 (9.1%) 18 (7.4%) Ns
Diagnostic 177 (73.5%) 186 (77.2%) Ns
Last colonoscopy (years)
1 to 3 50 51 Ns
3 to 5 25 26 Ns
5t o1 0 1 1 1 1 N s
> 10 8 10 Ns
Previous polyp resection 26 (10.8%) 19 (7.9%) Ns
Familial history of colorectal cancer 44 (18.3%) 36 (14.9%) Ns
Excellent/good bowel preparation 167 (69.3%) 162 (67.5%) Ns
*Not including polypectomy time.
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Page 4 of 13Table 2 Main findings from the comparison between narrow-band imaging group and conventional group
Outcome NBI group (n = 241) Conventional group (n = 241) Measurement of the intervention effect* Significance (p)
Total number of polyps (visual inspections) 77 102 RR 0.75 (0.60 to 0.96) 0.02
Proportion of patients with at least one polyp 50 (20.8%) 60 (24.9%) RR 0.83 (0.60 to 1.16) Ns
Mean number of polyps 0.32 (SD 0.73) 0.42 (SD 0.93) MD -0.1 (-0.25 to 0.05) Ns
Rate of polyp ≤ 5 mm 51 (21.2%) 62 (25.7%) RR 0.82 (0.59 to 1.14) Ns
Mean time to find the first polyp (seconds) 230.8 (SD 227.20) 220.81 (SD 233.93) MD 10.80 (-30.27 to 51.87) Ns
* Rate ratio (RR) and 95% CI or mean difference (MD) and 95% CI.
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3Table 3 Histological characteristic of polyps detected in the narrow-band imaging group and conventional group on a per-polyp basis
Outcomes
(Number of polyps by histological category)
NBI group (n = 241) Conventional group (n = 241) Measurement of the intervention effect* Significance (p)
Tubular adenoma or adenomatous polyp 46 47 0.98 (0.68 to 1.41) Ns
Hyperplastic polyps 22 42 0.52 (0.32 to 0.85) 0.009
Villous adenoma 1 1 1.00 (0.06 to 15.90) Ns
Tubulovillous adenoma 1 9 0.11 (0.01 to 0.87) 0.04
Adenocarcinoma 1 1 1.00 (0.06 to 15.90) Ns
Other type of lesions 2 1 2 (0.18 to 21.91) Ns
Total number of polyps 70 99 0.71 (0.55 to 0.91) 0.006
Total number of lesions 73 101 0.71 (0.57 to 0.92) 0.009
* Rate ratio (RR) and 95% CI or mean difference (MD) and 95% CI.
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3procedure among all participating endoscopists [26];
and a possible learning effect from the NBI during the
initial phase of the trial [19]. Only in one RCT each
patient underwent back-to-back colonoscopy [21]. The
primary outcomes of interest were frequently reported
incompletely and we had to impute standard deviations
in four studies [19,21,26,27].
A meta-analysis of studies (including diagnostic, sur-
veillance and/or screening colonoscopies) is showed in
Table 5. No significant differences were found among
groups in the mean number of polyps, the mean num-
ber of adenomas (Figure 3), and the rates of patients
with al least one polyp or one adenoma (Figure 4).
We performed a sensitive analysis comparing those
studies that used Lucera or Exera II systems. Signifi-
cant differences favoring the NBI system in the mean
number of polyps (2 RCT, 457 participants; WMD
-0.39 95% CI -0.62 to - 0.16; I2 0%) and the mean
number of adenomas (2 RCT, 457 participants; WMD
-0.22 95% CI -0.41 to - 0.04; I2 2%) were found when
pooling data from RCTs that used the Lucera system
[26,27].
No serious adverse events were reported. Taken into
account that we only found eight RCTs, funnel plots for
assessing publication bias was not performed.
Discussion
Main findings
According to our findings, the polyp detection rate per
patient by visual inspection was significantly higher in
the conventional colonoscopy group compared to the
NBI group. In addition, significant differences favoring
the conventional colonoscopy group were also found
for some types of histological examination polyps
Figure 2 Flow diagram of included and analysed randomized controlled trials.
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Page 7 of 13(hyperplastic polyps and tubulovillous adenoma). How-
ever, the adenoma detection rate was similar in both
groups.
Although meta-analysis of RCTs showed no significant
difference for pre-specified primary outcomes, individual
studies reported diverse findings [19-28]. Statistical het-
erogeneity may be explained by difference in the preva-
lence of polyps and adenomas in the population, the
indication for colonoscopy (screening, surveillance and/
or diagnostic), the age of the included population, and
the examiner’s experience among others. Findings of
our review update those of a previous systematic review
that included three RCTs concerning the detection of
colorectal adenomas [36].
Only two RCTs found a significant difference in the
mean rate of adenomas favouring the NBI group [21,26].
One RCT, which included 243 patients, found a significant
difference in the rate of adenoma detection favoring the
NBI group (22% vs. 14%), including the subgroups of
patients having polyps measuring less than 5 mm. The
authors of the study recommended the routine use of the
NBI system for surveillance of diminutive adenomas [26].
Another study [21] found that the NBI system significantly
increased the total number of adenomas detected as well
as the number of diminutive adenomas in the distal colon
[21]; however the rate of missed lesions between the NBI
and conventional group was similar. Another RCT found
that the number of diminutive (< 5 mm) adenomas was
significantly higher in the NBI group [26]. One RCT
reported a significantly higher detection in the mean num-
ber of flat adenomas in the NBI group [27], one study
reported the opposite [20] and two RCTs did not find any
significant difference [23,25].
In our study, colonoscopies were performed by experi-
enced examiners in both techniques and included diag-
nostic and screening colonoscopies from two different
Table 4 Characteristics of included studies in the meta-analysis
Study Methods Participants Interventions Primary
Outcomes
Risk of
bias*
Adler 2009 Open-label,
prospective,
randomized,
controlled,
multicenter trial
1256 patients, mean age, 64.4 years
(range 31-87 y) undergoing screening
colonoscopy
Wideangle colonoscopy using either
conventional high-resolution imaging or
NBI during instrument withdrawal (6
endoscopists). Exera II system.
Number of
adenomas/
number of
patients examined
Unclear
Adler 2008 Open-label,
prospective,
randomized,
controlled trial
401 patients with a mean age of 59.4
years (SD 13.4) undergoing diagnostic
colonoscopy
Wideangle colonoscopy using either
conventional high-resolution imaging or
NBI during instrument withdrawal (7
endoscopists). Exera II system.
Adenoma
detection rate
Unclear
East 2009
(abstract)
Open-label,
prospective,
randomized,
controlled trial
214 high risk adenomas patients with a
median age of 65 and 66 years in the
NBI and conventional group
respectively
Examination with NBI or white light (WLE),
with high definition (HDTV) colonoscopes
(3 endoscopists). Lucera system.
The number of
patients with at
least one
adenoma
detected.
Unclear
Inoue 2008 Open-label,
prospective,
randomized,
controlled trial
243 patients (NBI mean age, 61.1 SD
13.5; conventional mean age 62.9 SD
11.3) undergoing surveillance or
diagnostic colonoscopy
Colonoscopy using either conventional
high-resolution imaging or NBI during
instrument withdrawal (6 endoscopists).
Lucera system.
Mean number of
adenomas per
patient
Unclear
Kaltenbach
2008
Open-label,
prospective,
randomized,
controlled trial
276 patients with a mean age of 64
(SD 10) years (range 31 to 89),
undergoing screening, surveillance or
diagnostic colonoscopy
Wideangle colonoscopy using either
conventional high-resolution imaging or
NBI (6 endoscopists); back-to-back
colonoscopy by the same endoscopist.
Exera II system.
Neoplasm miss
rate.
Low
Paggi 2009 Open-label,
prospective,
randomized,
controlled trial
211 patients (from 50 to 69 years) with
positive immunologic fecal occult
blood tests
Colonoscopy withdrawal in white light
versus NBI (6 endoscopists). Exera II system.
The detection
rate of adenoma
Unclear
Rex 2007 Open-label,
prospective,
randomized,
controlled trial
434 patients aged 50 years or older
undergoing screening or surveillance
colonoscopy
Colonoscopy withdrawal in white light
versus NBI (only one endoscopist; high
definition monitors were used). Exera II
system.
Number of
adenomas
Unclear
Sabbagh
2011
Open-label,
prospective,
randomized,
controlled,
multicenter trial
482 patients with a mean age of 58.3
(SD 12.9) undergoing screening,
surveillance or diagnostic colonoscopy
Wideangle colonoscopy using either
conventional high-resolution imaging or
NBI (3 endoscopists). Exera II system.
Mean number of
adenomas
*The judgment for each entry involves answering a question, with answers “Yes” indicating low risk of bias, “No” indicating high risk of bias, and “Unclear”
indicating either lack of information or uncertainty over the potential for bias
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Page 8 of 13Table 5 Meta-analysis of studies comparing conventional colonoscopy to NBI system
Study (Year) Outcome Conventional colonoscopy (N) NBI system (N) RR* WMD** (95%CI) Heterogeneity (I2) §
Adler 2009
East 2009
Inoue 2008
Kaltenbach 2008
Sabbagh 2011
Mean number of polyps 1241 1238 WMD -0.07 (-0.21 to 0.07) 68%
Adler 2009
Adler 2008
East 2009
Inoue 2008
Kaltenbach 2008
Paggi 2009
Rex 2007
Sabbagh 2011
Mean number of adenomas 1768 1749 WMD -0.08 (-0.17 to 0.01) 62%
Adler 2009
Adler 2008
Inoue 2008
Kaltenbach 2008
Sabbagh 2011
Rate of patients with al least one polyp 1336 1330 RR 0.90 (0.73 to1.11) 70%
Adler 2009
Adler 2008
East 2009
Inoue 2008
Kaltenbach 2008
Paggi 2009
Rex 2007
Sabbagh 2011
Rate of patients with at least one adenoma 1763 1749 RR 0.96 (0,88 to 1.04) 0%
Adler 2009
Adler 2008
Paggi 2009
Sabbagh 2011
Rate of patients with carcinoma 1181 1169 RR 1.20 (0.58 to 2.47) 0%
*Relative Risk and 95% confidence intervals (CI) for dichotomous outcomes were calculated by the Mantel-Haenszel fixed-effects model when I2 < 50%. Relative Risk and 95% confidence intervals (CI) for
dichotomous outcomes were calculated by the Mantel-Haenszel random-effects model when I2 > 50%.
**Mean difference and 95% confidence intervals (CI) for continuous outcomes were calculated using the inverse variance and the fixed-effects model when I2 < 50%. Mean difference and 95% confidence intervals
(CI) for continuous outcomes were calculated using the inverse variance and the random-effects model when I2 > 50%.
§ Low, moderate, and high levels of heterogeneity approximately correspond to I2 values of 25%, 50% and 75%, respectively [35].
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3institutions. Adenoma rates in larger colonoscopy trials
vary widely. The overall detection rate of polyps and
adenomas by histological examination were 35.1% and
22% respectively, which is similar to the rates reported
in other studies [20,37-40]. However some RCTs found
higher rates of polyps and adenomas; the difference can
be explained by heterogeneous included population. The
lower detection rate in our study may be due to the
withdrawal time but also to the lower prevalence in our
population. A number of published studies have
evaluated the prevalence of polyps and adenomas in
Colombia. Overall, the prevalence of colonic adenomas
is lower when compared with rates reported in other
regions [41-44]. In addition, around one third of
patients in our RCT had already had a colonoscopy.
Although differences in polyp frequency between
screening and diagnostic colonoscopy have been
reported, some studies have found similar rates [40].
Additionally, no differences were found in primary out-
comes between colonoscopies performed in the two
Figure 3 Meta-analyses of the mean number of adenomas.
Figure 4 Meta-analyses of the rates of patients with at least one adenoma.
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Page 10 of 13different clinics, or when different periods of time were
compared (first 241 colonoscopies vs. last 241
colonoscopies).
Limitations of the study
The findings of this RCT have some limitations, mostly
due to the lack of tandem colonoscopy in both groups.
Difference in the overall rate of polyps could have been
due to selection bias (patients with more polyps could
have been included in the conventional group by chance).
However, we found no significant differences among par-
ticipants in the baseline characteristics and the colono-
scopy performance; we included a significant number of
patients and we concealed the allocation of patients to
minimize any possible bias. Our data shows that the
white-light group had 20.8% higher detection rate of ade-
nomas than did the NBI group. As both groups had simi-
lar withdrawal time, the white-light group could have
had better mucosal visualization during the withdrawal
phase compared to that of the NBI group (the darkening
of the image associated with the use of NBI). This may
have lead to the finding of significantly greater number of
polyps found in the white-light group.
In addition, the fact that bowel preparation was not excel-
lent in one third of patients may have contributed to the
poorer performance of the NBI visualization. As screening
colonoscopy is not usually recommended in our country in
people above 50 years of age with average risk, we had an
important proportion of diagnostic colonoscopies.
Concerning the review, we pooled data from studies
that included heterogeneous populations and indica-
tions. The use of varied endoscopic systems as well as
differences in colon preparation of participants between
studies may have had some impact on findings. Uraoka
et al noticed that significant differences in the detection
of adenomas where related to the type of endoscopic
video system (either the sequential LUCERA series or
the simultaneous EXERA-II series). They found that
most positive studies used the LUCERA system while all
of the negative studies used the EXERA-II system [45].
Although pooled estimates from two RCTs [26,27] sup-
port the use of LUCERA series, both studies where
judged as having unclear risk of bias. More research is
still needed to determine the efficacy of different NBI
system settings for screening and surveillance colonos-
copies, particularly to enhance the detection rate for flat
adenomatous lesions [45].
Finally, there were differences in the report of flat or
non-polypoid type neoplasm among studies which did
not permit further pooled analysis.
Conclusion
This RCT in two homogeneous practices did not show
any objective advantage of the NBI technique over the
conventional colonoscopy in terms of improved ade-
noma detection rate. Pooled estimated of published
RCT showed no benefits of the NBI system over the
conventional colonoscopy in terms of the mean num-
ber of polyps and the mean number of adenomas
identified.
Appendix 1. Search strategy for PUBMED
((randomized controlled trial [pt] OR controlled clinical
trial [pt] OR randomized [tiab] OR placebo [tiab] OR
drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR
groups [tiab]) NOT (animals [mh] NOT (humans [mh]
AND animals [mh]))) AND (Colonoscopy [mh] OR
colonosco* [tw] OR (intestin* endoscop* [tw])) AND
(narrow band [tw] OR NBI [tw])
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